Cargando…

EGFR-TKIs与化疗比较一线治疗非小细胞肺癌疗效的meta分析

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been used for the first-line treatment of non-small cell lung cancer (NSCLC) and has shown good clinical effects. However, some patients fail to benefit from this treatment. The aim of this study is t...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000008/
https://www.ncbi.nlm.nih.gov/pubmed/25800570
http://dx.doi.org/10.3779/j.issn.1009-3419.2015.03.04